1. Home
  2. NBIX vs NVMI Comparison

NBIX vs NVMI Comparison

Compare NBIX & NVMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$130.72

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Nova Ltd.

NVMI

Nova Ltd.

HOLD

Current Price

$499.85

Market Cap

15.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
NVMI
Founded
1992
1993
Country
United States
Israel
Employees
N/A
1612
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
15.9B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
NBIX
NVMI
Price
$130.72
$499.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
22
8
Target Price
$180.91
$431.88
AVG Volume (30 Days)
1.1M
270.3K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
41.95
N/A
EPS
4.67
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$20.94
Revenue Next Year
$13.14
$19.53
P/E Ratio
$27.48
$56.79
Revenue Growth
977.51
N/A
52 Week Low
$105.50
$176.52
52 Week High
$160.18
$550.00

Technical Indicators

Market Signals
Indicator
NBIX
NVMI
Relative Strength Index (RSI) 51.13 52.01
Support Level $124.62 $406.18
Resistance Level $135.88 $501.14
Average True Range (ATR) 3.58 18.32
MACD -0.12 -2.26
Stochastic Oscillator 59.98 15.00

Price Performance

Historical Comparison
NBIX
NVMI

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About NVMI Nova Ltd.

Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.

Share on Social Networks: